A detailed history of Jane Street Group, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 383,563 shares of EXEL stock, worth $13.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
383,563
Previous 291,448 31.61%
Holding current value
$13.9 Million
Previous $6.92 Million 24.61%
% of portfolio
0.01%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$20.34 - $23.73 $1.87 Million - $2.19 Million
92,115 Added 31.61%
383,563 $8.62 Million
Q1 2024

May 15, 2024

SELL
$20.17 - $23.93 $287,079 - $340,595
-14,233 Reduced 4.66%
291,448 $6.92 Million
Q4 2023

Feb 14, 2024

SELL
$19.25 - $24.13 $1.65 Million - $2.07 Million
-85,780 Reduced 21.91%
305,681 $7.33 Million
Q3 2023

Nov 14, 2023

BUY
$19.04 - $22.74 $2.65 Million - $3.17 Million
139,296 Added 55.24%
391,461 $8.55 Million
Q2 2023

Aug 14, 2023

SELL
$18.17 - $20.48 $3.81 Million - $4.29 Million
-209,425 Reduced 45.37%
252,165 $4.82 Million
Q1 2023

May 15, 2023

BUY
$16.3 - $19.41 $7.52 Million - $8.96 Million
461,590 New
461,590 $8.96 Million
Q3 2022

Nov 14, 2022

BUY
$15.68 - $22.27 $1.89 Million - $2.68 Million
120,439 Added 91.0%
252,789 $3.96 Million
Q2 2022

Aug 16, 2022

BUY
$17.44 - $23.16 $869,244 - $1.15 Million
49,842 Added 60.41%
132,350 $2.76 Million
Q1 2022

May 17, 2022

SELL
$17.03 - $22.67 $1.13 Million - $1.5 Million
-66,068 Reduced 44.47%
82,508 $1.87 Million
Q4 2021

Feb 15, 2022

BUY
$15.84 - $21.88 $591,829 - $817,502
37,363 Added 33.6%
148,576 $2.72 Million
Q3 2021

Nov 16, 2021

SELL
$16.3 - $21.14 $514,656 - $667,474
-31,574 Reduced 22.11%
111,213 $2.35 Million
Q2 2021

Aug 16, 2021

BUY
$17.95 - $25.56 $609,510 - $867,915
33,956 Added 31.2%
142,787 $2.6 Million
Q1 2021

May 18, 2021

SELL
$20.53 - $25.22 $783,465 - $962,445
-38,162 Reduced 25.96%
108,831 $2.46 Million
Q4 2020

Feb 17, 2021

BUY
$18.39 - $24.8 $684,236 - $922,733
37,207 Added 33.89%
146,993 $2.95 Million
Q3 2020

Nov 17, 2020

BUY
$20.67 - $26.94 $1.92 Million - $2.5 Million
92,732 Added 543.76%
109,786 $2.69 Million
Q2 2020

Aug 17, 2020

SELL
$16.46 - $27.42 $938 - $1,562
-57 Reduced 0.33%
17,054 $405,000
Q1 2020

May 15, 2020

SELL
$14.46 - $21.8 $1.67 Million - $2.51 Million
-115,242 Reduced 87.07%
17,111 $295,000
Q4 2019

Feb 14, 2020

BUY
$15.15 - $18.89 $981,462 - $1.22 Million
64,783 Added 95.88%
132,353 $2.33 Million
Q3 2019

Nov 14, 2019

BUY
$17.68 - $22.65 $737,804 - $945,207
41,731 Added 161.5%
67,570 $1.2 Million
Q2 2019

Aug 15, 2019

SELL
$18.93 - $24.75 $1.19 Million - $1.56 Million
-62,972 Reduced 70.91%
25,839 $553,000
Q1 2019

May 16, 2019

SELL
$19.6 - $24.76 $157,231 - $198,624
-8,022 Reduced 8.28%
88,811 $2.11 Million
Q4 2018

Feb 15, 2019

SELL
$13.65 - $21.8 $645,685 - $1.03 Million
-47,303 Reduced 32.82%
96,833 $1.91 Million
Q3 2018

Nov 14, 2018

BUY
$15.87 - $22.4 $1.4 Million - $1.98 Million
88,338 Added 158.32%
144,136 $2.55 Million
Q1 2018

May 15, 2018

BUY
$22.15 - $31.89 $342,837 - $493,593
15,478 Added 38.39%
55,798 $1.24 Million
Q4 2017

Feb 15, 2018

SELL
$24.23 - $30.93 $481,377 - $614,486
-19,867 Reduced 33.01%
40,320 $1.23 Million
Q3 2017

Nov 14, 2017

BUY
$23.35 - $29.24 $1.41 Million - $1.76 Million
60,187
60,187 $1.46 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.7B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.